Advertisement
News
Subscribe to MDT Magazine News

Wheelchair Makes the Most of Brain Control

September 12, 2010 8:32 pm | by Massachusetts Institute of Technology | Comments

Artificial intelligence improves a wheelchair system that could give paralyzed people greater mobility.

TOPICS:

Gene discovery could yield treatments for nearsightedness

September 12, 2010 11:32 am | by EurekAlert | Comments

(Duke University Medical Center) Myopia (nearsightedness) is the most common eye disorder in the world and becoming more common, yet little is known about its genetic underpinnings. Scientists at Duke University Medical Center, in conjunction with several other groups, have...

TOPICS:

Free Dog Heart Checks at McAllister Park

September 11, 2010 4:35 pm | by Bio-Medicine.Org | Comments

SAN ANTONIO, Sept. 11 /- The Mobile Dog Heart Health Tour is heading south to San Antonio, Texas, for an afternoon of free heart health examinations in San Antonio's McAllister Dog Park. From 3 p.m. to 8 p.m. on September 17, certified veterinary cardiologists will be performing on site...

TOPICS:
Advertisement

Covidien Supports FDA's Patient Safety Efforts for Gadolinium-Based Contrast Agents

September 10, 2010 5:36 pm | by Covidien | Comments

ST. LOUIS, Sep 10, 2010 (BUSINESS WIRE) --Covidien (NYSE:COV), a leading global provider of healthcare products, today announced it supports the U.S. Food and Drug Administration's (FDA) labeling changes for gadolinium-based contrast agents for patients with acute kidney injury or...

TOPICS:

3M begins tender offer for Cogent shares

September 10, 2010 4:45 pm | by The Associated Press | Comments

3M Co., which makes Post-Its and various other products, said Friday it has begun a tender offer for all outstanding shares of security device developer Cogent Inc. at $10.50 a share.3M agreed to buy Cogent last month for about $943 million in a bid to expand into the security market.The board...

Covance to Present at Morgan Stanley Global Healthcare Conference

September 10, 2010 1:36 pm | by Bio-Medicine.Org | Comments

PRINCETON, N.J., Sept. 10 /- Covance Inc. (NYSE: CVD ) today announced that it will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 14, 2010 at 2:10 p.m. ET.  Investors may access a live webcast of the presentation at www.covance.com .  In order...

TOPICS:

FDA Approves New Dosing for FASLODEX® (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women

September 10, 2010 1:36 pm | by Bio-Medicine.Org | Comments

WILMINGTON, Del., Sept. 10 /- AstraZeneca (NYSE: AZN ) today announced that the U.S. Food and Drug Administration (FDA) has approved the 500mg dose of FASLODEX® (fulvestrant) Injection , replacing the previously approved monthly dose of 250mg, for the treatment of hormone...

TOPICS:

SME Announces 2011 Election Results for International Directors and Member Council

September 10, 2010 11:33 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., September 9, 2010 — The Society of Manufacturing Engineers (SME) announces the election of six new members to its Board of Directors and four new members to its Member Council for the 2011-12 term; one individual was also elected to serve a one-year term as an...

Advertisement

Hospira Symbiq One-Channel and Two-Channel Infusers: Class I Recall

September 10, 2010 11:33 am | by U.S. Food & Drug Administration | Comments

Potential for the device to fail to detect air in line at the end of an infusion.

Study to control blood pressure in diabetics enrolling

September 10, 2010 11:32 am | by Baylor College of Medicine | Comments

Most people believe controlling blood sugar levels is the only concern for people with diabetes. However, doctors at Baylor College of Medicine say there are more health concerns that must be managed to save the life of a diabetic. "One of the leading causes of death for people with...

TOPICS:

CIOs 'cautiously optimistic' of stimulus funds for e-health records

September 10, 2010 10:34 am | by Mass High Tech: The Journal of New England Technology | Comments

A survey conducted by the College of Health Information Management Executives (CHIME) indicated that 90 percent of CHIME member respondents expect to qualify for stimulus funding by the end of Stage 1 of the incentive program, Sept. 30, 2012.

Sysmex America Announces LabCorp Hematology Automation Agreement

September 10, 2010 10:32 am | by Bio-Medicine.Org | Comments

MUNDELEIN, Ill., Sept. 10 /- Sysmex America, Inc. (SAI), a leading medical diagnostic instrument manufacturer and information systems developer, today announced that Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH ) has signed a five-year agreement for Sysmex...

TOPICS:

CorMatrix Receives FDA IDE Approval to Begin Prospective, Randomized Evaluation of New Onset Postoperative Atrial Fibrillation in Subjects Receiving the CorMatrix® ECM™ for P...

September 10, 2010 9:32 am | by Bio-Medicine.Org | Comments

ATLANTA, Sept. 10 /- CorMatrix Cardiovascular, Inc., a medical device company developing and delivering unique extracellular matrix (ECM) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, announced today that FDA has granted conditional...

TOPICS:

Cogdell Spencer Inc. Declares Quarterly Dividend

September 10, 2010 9:31 am | by Bio-Medicine.Org | Comments

CHARLOTTE, N.C., Sept. 10 /- Cogdell Spencer Inc. (NYSE: CSA ) announced today that its Board of Directors has declared a quarterly dividend of $0.10 per common share payable on October 20, 2010 to stockholders of record on September 24, 2010.  The dividend covers the third quarter...

TOPICS:

Orexigen® Therapeutics to Speak at Rodman & Renshaw Annual Global Investment Conference

September 10, 2010 8:34 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Sept. 10 /- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company focused on the treatment of obesity, today announced that the Company will be speaking at the Rodman & Renshaw Annual Global Investment Conference.  The details are as...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading